Internal Medicine, Nephrology · Vero Beach, FL
NPI
1700205523
Since 2014
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
1050 37th Pl Ste 104
Vero Beach, FL, 32960
Phone (772) 978-5811
Groups this clinician bills Medicare through
Medicare paid, 2024
$392K
2,932 services
Medicare patients, 2024
685
Average age 76
Drug cost, 2024
$140K
1,567 prescriptions
Company payments, 2025
$78.96
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pablo E Puello Diaz was code 90966 (esrd related services (not dialysis)), 603 times for 160 patients. In total Pablo E Puello Diaz billed 2,932 services in 29 codes, and Medicare paid $392K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90966 ESRD Related Services (not dialysis) | Facility | 603 | 160 | $243.10 | $147K |
| 99233 Hospital E&M - Subsequent | Facility | 557 | 170 | $98.78 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 436 | 220 | $13.39 | $5,840 |
| 90960 ESRD Related Services (not dialysis) | Office | 268 | 59 | $291.88 | $78K |
| 99212 Office E&M - Established | Office | 210 | 152 | $45.95 | $9,650 |
| 99232 Hospital E&M - Subsequent | Facility | 173 | 77 | $65.59 | $11K |
| 99222 Hospital E&M - Initial | Facility | 147 | 130 | $107.12 | $16K |
| 90966 ESRD Related Services (not dialysis) | Office | 107 | 26 | $233.71 | $25K |
| 99213 Office E&M - Established | Office | 79 | 64 | $72.07 | $5,694 |
| 99305 SNF E&M | Facility | 52 | 49 | $111.11 | $5,778 |
| 99215 Office E&M - Established | Office | 43 | 37 | $144.17 | $6,199 |
| 99214 Office E&M - Established | Office | 38 | 36 | $102.85 | $3,908 |
| 99223 Hospital E&M - Initial | Facility | 35 | 31 | $144.35 | $5,052 |
| 99203 Office E&M - New | Office | 35 | 35 | $93.16 | $3,260 |
| 99202 Office E&M - New | Office | 25 | 25 | $58.07 | $1,452 |
By year: 2022 $243K for 1,881 services; 2023 $261K for 2,138 services; 2024 $392K for 2,932 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pablo E Puello Diaz prescribed most often to Medicare patients was Prosol (Parenteral Amino Acid 20% No.1), with 256 prescriptions and refills. In total Pablo E Puello Diaz wrote 1,567 Medicare prescriptions that cost $140K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prosol Parenteral Amino Acid 20% No.1 | 256 | 256 | 15 | $46K |
| Amlodipine Besylate Generic | 170 | 470 | 65 | $1,394 |
| Furosemide Generic | 147 | 357 | 57 | $722 |
| Glipizide Er Glipizide | 89 | 257 | 31 | $1,015 |
| Hydralazine Hcl Generic | 61 | 161 | 25 | $1,417 |
| Losartan Potassium Generic | 49 | 123 | 19 | $285 |
| Chlorthalidone Generic | 39 | 103 | 15 | $669 |
| Hydrochlorothiazide Generic | 35 | 98 | 13 | $175 |
| Calcium Acetate Generic | 32 | 55 | 11 | $2,503 |
| Lisinopril Generic | 31 | 66 | Under 11 | $158 |
| Nifedipine Er Nifedipine | 30 | 65 | Under 11 | $1,559 |
| Glipizide Generic | 30 | 82 | 15 | $161 |
| Clinisol Parenteral Amino Acid 15% No.5 | 29 | 29 | Under 11 | $5,317 |
| Carvedilol Generic | 27 | 81 | 12 | $303 |
| Midodrine Hcl Generic | 26 | 52 | Under 11 | $1,624 |
Brand drugs: 372 claims; generic drugs: 1,195 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pablo E Puello Diaz $78.96 ($78.96 in general payments such as food, travel and fees) from 3 companies. The largest payer was Ardelyx, Inc. with $50.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.